23andMe, Inc. SOUTH SAN FRANCISCO, Calif., May 9, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with...
All Key Financial Results Above the High-End of Guidance Range LOS ANGELES, May 09, 2024–(BUSINESS WIRE)–System1, Inc. (NYSE: SST) (“System1” or the “Company”), an omnichannel customer...